First Tracks Biotherapeutics, Inc. (TRAX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $43.57
- As of
Kresmion compiles this page from TRAX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
First Tracks Biotherapeutics, Inc. (TRAX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-03.
See the full TRAX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TRAX on one page. Preview it with sample data, then open it live with a free account.
Preview the TRAX dossierActive events for TRAX
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in TRAX
- high13F: funds added
3 tracked funds increased TRAX this 2026Q2, institutional consensus
- mediumEarnings below estimates
Q2-2026: Missed consensus by 12.0%, EPS $-0.95 vs $-0.8485 estimate
- medium13F: new position
CITADEL ADVISORS LLC new position in TRAX
- medium13F: new position
Point72 Asset Management, L.P. new position in TRAX
FREE, NO ACCOUNT
Every event on TRAX, as it fires
You are seeing 5 of 7 events recorded on TRAX since 2026-06-24.
The five above landed across 4 days. The other 2 were recorded on 1 other days. 4 of the 7 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
TRAX positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 337185102 · 2026Q3 | $1.5M | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, TRAX
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on TRAX
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in TRAX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TRAX in the last 180 days.
Upstream: SEC EDGAR filings for TRAX
Kresmion, "First Tracks Biotherapeutics, Inc. (TRAX) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/TRAX. Upstream data: SEC EDGAR filings for TRAX.
Link to this data (HTML):
<a href="https://kresmion.com/research/TRAX">First Tracks Biotherapeutics, Inc. (TRAX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow TRAX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TRAX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.